Literature DB >> 25293620

Irreversible electroporation: a novel therapy for stage III pancreatic cancer.

Matthew J Weiss, Christopher L Wolfgang.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25293620     DOI： 10.1016/j.yasu.2014.05.002

Source DB:  PubMed          Journal:  Adv Surg        ISSN： 0065-3411


× No keyword cloud information.
  5 in total

Review 1.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

Review 2.  Irreversible electroporation in primary and metastatic hepatic malignancies: A review.

Authors:  Tianchu Lyu; Xifu Wang; Zhanliang Su; Junjie Shangguan; Chong Sun; Matteo Figini; Jian Wang; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer.

Authors:  Chaobin He; Jun Wang; Shuxin Sun; Yu Zhang; Shengping Li
Journal:  J Oncol       Date:  2019-05-12       Impact factor: 4.375

4.  Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.

Authors:  Chaobin He; Xin Huang; Yu Zhang; Zhiyuan Cai; Xiaojun Lin; Shengping Li
Journal:  Front Oncol       Date:  2020-01-22       Impact factor: 6.244

5.  Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.

Authors:  Daniel Delitto; Daniel J Zabransky; Fangluo Chen; Elizabeth D Thompson; Jacquelyn W Zimmerman; Todd D Armstrong; James M Leatherman; Reecha Suri; Tamara Y Lopez-Vidal; Amanda L Huff; Melissa R Lyman; Samantha R Guinn; Marina Baretti; Luciane T Kagohara; Won Jin Ho; Nilofer S Azad; William R Burns; Jin He; Christopher L Wolfgang; Richard A Burkhart; Lei Zheng; Mark Yarchoan; Neeha Zaidi; Elizabeth M Jaffee
Journal:  Oncoimmunology       Date:  2021-11-08       Impact factor: 7.723
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.